Presentation Material
for the year ended Dec. 31, 2022
February 17, 2023
NAKANISHI INC.

Disclaimer
T h e i n f or m at i on p r e s en t ed i n t h es e m at er i al s c on t ai n s for w a r d - l o o k i n g s t at e m en t s ab ou t fut ur ebusiness performance. These statements by definition involve risks and uncertainties and are not intended to guarantee
future performance. Actual results in the future may differ from expectations and the projections presented in thesematerials due to changes in the global economy and fluctuations in foreign currency exchange rates and so on. N
SChanges in reporting segments
Key changes

Previous reporting segments

1. “Surgical Business” was separated from the previous reporting segment “Dental Products” andindividually established
2. Abolition of the previous reporting segment “Others (mainly included repair services)”, which will be
included in each new reporting segments

New reporting segments
RenameDental Products

Dental BusinessStarting from FY2022 Q1Development, production and sales of wide range ofdental equipment, which cover such as restorative
dentistry, periodontics, mobile dental care, oral
surgery etc.

Separate

Surgical Business

RenameIndustrial Products

Industrial Business

OthersAbolition© 2023 NAKANISHI INC.

Development, production and sales of bone grinding
and cutting drills which can be used in areas ofneurosurgery, spine surgery and orthopedic surgery.

Development, production and sales of motors andspindles which can be used in high-precision
processes in wide range of industrial areas such as
automobile, aircraft, precision parts industries.

2

Product lineup
Dental business

Dental hand piece

Oral surgery system

Oral hygiene system

ConsoleSlim motor

Attachment

Controller

SpindleMicro grinder

Clinical micromotor

Surgical businessBur

Industrial business© 2023 NAKANISHI INC.

Ultrasonic grinder3

Consolidated financial forecast for FY2023

Consolidated financial result for FY2022

P. 5

Consolidated financial forecast for FY2023

P. 16

Overviews of each segment and future initiatives

P. 20© 2023 NAKANISHI INC.

4

Consolidated financial resultfor FY2022

5

Performance highlights of FY2022

A

chieved record-high performance for the past two consecutive years by capturingstrong global demand. Maintained the same sales level as the previous fiscal year
when significant increase in sales had been achieved, even excluding the forex impact.

Due to the successful parts purchasing and design changes, we could minimize
impact on production. Promoted preparation for the future increased productionof parts and enhanced productivity at new factory “A1 +”.

Parts prices remained high while parts shortages were slightly eased at the end of
the fiscal year. Due in part to chronic vacancies at production sites caused by the
COVID infection, the prolonged delivery dates could not have been improved, which isleading to the exposition of the competitive risk.

© 2023 NAKANISHI INC.

6

Consolidated profit and loss statement
M of JPY

FY2022

FY2021YoY Comparison

FY2022 Forecast

ActualActualAmountRatio

Upward revisionon Nov. 11

Net sales

48,67144,857+3,813+8.5 %

48,588+0.2 %

Gross profit

31,221

27,295+3,926+14.4 %

30,942+0.9 %

64.1 %

60.8 %+3.3 pt—

15,38913,750+1,638+11.9 %

31.6 %

30.7 %+1.0 pt—

17,646

13,951+3,694+26.5 %

36.3 %

31.1 %+5.2 pt—

12,471

10,102+2,368+23.4 %

Ratio to net sales

25.6 %

22.5 %+3.1 pt—

25.9 %

JPY

145.48116.73——146.47- Against the US dollar

JPY

130.77109.84+20.93124.00+6.77- Against the EUROJPY

137.90130.08+7.82

131.00+6.90

Ratio to net sales

Operating profit
Ratio to net sales

Ordinary profit
Ratio to net sales

Profit attributable toowners of parent

EPS

63.7 %

14,91830.7 %

18,02437.1 %

12,573

vs. Forecast—+3.2 %—-2.1 %—-0.8 %—

Currency rate

Forex impact :Net sales +3,342M of JPY

vs FY2021 Actual), +1,629M of JPY

vs FY2022 Forecast

Forex sensitivity :Fluctuation in annual net sales due to the depreciation of the yen (per one yen)
Against USD: Increase of 90M of JPY Against EURO: Increase of 78M of JPY© 2023 NAKANISHI INC.

7

Transition of earnings structure
M of JPY

AmountComposition ratio

60,00048,671

Net sales
50,00044,857COGS

Net sales
YoY

17,56220,000+3,813

80%

+8.5%

COGS%

13,544

15,832

35.9%

30.2%

32.5%

50%

SGA%

30%

20%

15,3890

FY2021
ActualSGA%
YoY+2.3 pt40%+11.9%

13,750Costs of overseas sales weredecreased due to thedepreciation of yen

60%+1,638
OP

39.1%

70%

OP
YoY

10,000

COGS%
YoY-3.2 pt90%

Excluding the forex impact,
net sales increased slightly
year on year

30,000SGA

48,671

100%

17,44940,00044,857

Net sales

Increase of SGA was offset byincrease of gross profit led by
the depreciation of yen

OP margin

FY2022
Actual© 2023 NAKANISHI INC.

30.7%

31.6%

FY2021
ActualFY2022
ActualGlobal marketing activities went
back to the level of before the
COVID-19 pandemic

10%

0%

8

Change in net sales by business segment
M of JPY+ 3,813

24,000+ 8.5%
22,000+398
Surgical

20,00044,857+2,669+14.4%+745

FY2021
ActualFY2022
ActualChangeDental

38,25740,926+7.0 %

Surgical

2,761

3,160

+14.4 %

Industrial

3,839

4,584

+19.4 %

44,857

48,671+8.5 %

48,671

Industrial+19.4%

18,000Dental+7.0%
16,00014,000Total

12,000Forex impact+3,342 M of JPY +7.5%

10,000

FY2021
ActualFY2022
Actual© 2023 NAKANISHI INC.

9

Change in net sales by region
M of JPY+ 3,813

FY2021
ActualFY2022
ActualChange

Japan

9,439

8,891

-5.8 %

Europe14,01015,432+10.2 %

24,000+ 8.5%

48,671

22,000+2,33620,00044,85718,000

-547
Japan
-5.8%

16,000

-89

+692

Asia
-1.2%

Others+11.7%+1,421 N. America

N. America

8,284

10,620+28.2 %

Europe+10.2%

Asia

7,180

7,091

-1.2 %

Others

5,943

6,636

+11.7 %

Total

44,857

48,671+8.5 %+28.2%

14,00012,000Forex impact
impactForex+3,342+7.5%+2,286M of JPY +6.8%

10,000

FY2021
ActualFY2022
Actual© 2023 NAKANISHI INC.

10

Change in operating profit by segment
M of JPY+ 1,638

7,300

+268
Surgical+20.6%

6,800

+305

-402

Industrial+22.2%

Corporate
expenses

15,389

+1,467

6,300

5,800

FY2021
ActualFY2022
ActualChangeDental

15,556

17,024+9.4 %

Surgical

1,303

1,571

+20.6 %

Industrial

1,377

1,683

+22.2 %

Corporate
expenses-4,487-4,890Total

13,75015,389+ 11.9%7,800

13,750Dental
+9.4%

5,300

4,800

4,300

+11.9 %

3,800

Forex impact+2,565 M of JPY +18.7%

3,300

FY2021
ActualFY2022
Actual© 2023 NAKANISHI INC.

11

Change in operating profit
M of JPY
FY2021
Average+ 1,638USD

JPY 109.84→

JPY 130.77

EURO

JPY 130.08→

JPY 137.90+ 11.9%8,000

FY2022Average

15,389

7,000

6,000

13,750+ 286
Increasein demand

5,000

+ 297

-378

Product mix-199

Increase in
Increase in
selling expenses
personnel
expenses

4,000+ 2,565-933
Increase inForex impact
other expenses

3,000

2,000

1,000

Based on forex as of FY2021
0

FY2021
ActualFY2022
Actual© 2023 NAKANISHI INC.

12

OP profit and profit attributable to owners of parent
M of JPY

15,389Operating profit

Non-operating profit

2,629

Non-operating expenses

372

Ordinary profit

17,646Extraordinary income

70419

Extraordinary losses

17,297

Profit before income taxes

Non-operating
profitDividends income
Equity in earnings of affiliates
Foreign exchange gain

638
812
610

Non-operating
expenses

Loss on investments inmoney held in trust

282

Extraordinary
incomeGain on sales of non-current assets

70

Extraordinary
lossesImpairment losses

374

4,823

Total income taxes

12,471

Profit attributable to owners of parent
300

2,300

4,300

6,300

8,300

10,300© 2023 NAKANISHI INC.

12,30013

Consolidated balance sheet
M of JPY

As of Dec. 31,
2022

As of Dec. 31,
2021

Change102,154

94,460+7,69334,992
6,106
16,28435,984
5,348
11,733-991+757+4,551

11,131

11,541-409

Account payable - trade
Income taxes payable
Other current liabilities

+526
+234
-1,604

480

100

+380

Long-term borrowings+358

91,022

82,919+8,10393,62884,765+8,863Return on equity (ROE)

14.4 %

12.7 %+1.7 pt

Return on assets (ROA)

18.0 %

15.8 %+2.2 pt

FY2022
ActualFY2021
ActualChangeCapital investments

4,058

2,415

+1,642

Depreciation expenses

2,049

1,807

+241

Total assets- Cash and deposits- Notes and accounts receivable - trade- Inventories

Liabilities- Loans payable

Net assets- Retained earnings© 2023 NAKANISHI INC.

Note
Buildings and structures+2,680

Merchandise and finished goods +1,344
Work in process+1,512
Raw materials and supplies+1,694

Treasury shares-2,500Foreign currency translation reserve+2,131Note
New factory “A1+”Information system

1,469
276

14

Consolidated cash flow statement
M of JPY
25,000C a sh fl o w s f ro m
operating activities

23,000C a sh fl o w s f ro m
investing activities

C a s h fl o w s f ro mfinancing activities

Effect of exchange
rate change

21,000-6,31419,000+7,76417,00015,00034,887

13,000Purchase of non-current
assets-3,984
Profit before
income taxes+17,297

Depreciation+2,049

Income taxes paid -5,328

11,000

Increasein inventories

Purchase of investments
in subsidiaries resulting
in change in scope ofConsolidation-3,606

31,648+1,418-3,6659,000

Free cash flows

1,450

7,000

-6,107

Dividends paid

-3,607Purchase oftreasury shares-2,5005,000

Cash and cash equivalents at
beginning of period2022/01

Cash and cash equivalents at
end of period2022/12© 2023 NAKANISHI INC.

15

Consolidated financial forecast
for FY2023

16

Consolidated financial forecast for FY2023
M of JPY

FY2023

FY2022

Forecast

ActualAmountRatio

Net sales

52,272

48,671+3,601+7.4 %

Gross profit

33,96531,221+2,743+8.8 %

65.0 %

64.1 %+0.8 pt—

15,07015,389-318-2.1 %

28.8 %

31.6 %-2.8 pt—

15,836

17,646-1,810-10.3 %

30.3 %

36.3 %-6.0 pt—

10,976

12,471-1,494-12.0 %

Ratio to net sales

21.0 %

25.6 %-4.6 pt—(JPY)

128.91145.48——

Capital investments

5,750

4,058

+1,692+41.7 %

Depreciation expenses

2,221

2,049

+172

+8.4 %

Ratio to net sales

Operating profit
Ratio to net sales

Ordinary profit
Ratio to net sales

Profit attributableto owners of parent

EPS

ChangeNote

New factory “M1”, etc.

Currency rate
- Against the US dollar

JPY

125.00130.77-5.77—

Forex sensitivity: 94Mof JPY- Against the EUROJPY

135.00137.90-2.90—

Forex sensitivity: 98Mof JPY© 2023 NAKANISHI INC.

17

Change in net sales by business segment
M of JPY+ 3,601+ 7.4%

15,00014,000+2,357

FY2023
Forecast

ChangeDental

40,92643,516+6.3 %

Surgical

3,160

3,137

-0.7 %

Industrial

4,584

6,942

+51.4 %−

-1,324-2.7%

48,671

52,272+7.4 %

52,272-22

13,000Surgical Industrial

12,000+2,59011,00010,000-1,324FY2022
Actual-0.7%+51.4%

48,671
Dental

9,000

+6.3%
Forex
impact

8,000

7,000

6,000

Total

5,000

FY2022
ActualFY2023
Forecast© 2023 NAKANISHI INC.

18

Change in operating profit
M of JPY
FY2022
Actual- 318

FY2023
Forecast

USD

130.77 JPY→

125.00 JPY

EURO

137.90 JPY→

135.00 JPY

11,000- 2.1%
10,000

9,000

8,000

7,000

+ 908

-890

Product mix

Increase in
selling expenses-2,104+ 3,159

15,3896,000

Increasein demand-426
Increase inpersonnel
expenses

Increase inother expenses-966

15,070Forex impact

5,000

4,000

3,000

Based on forex as of FY2022
2,000

FY2022
ActualFY2023
Forecast© 2023 NAKANISHI INC.

19

Overviews of each segment
and future initiatives

20

History of consolidated net sales
Achieved record-high sales for the past two consecutive years.
Maintained the same level as the previous year even excluding the forex impact.
Q1
6,000

Q2

Q3

Q4

11.9

12.4 BofJPY

11.6 BofJPY

12.5 BofJPY

YoY+0.6 B of JPY

YoY+0.8 B of JPY

YoY+1.1 B of JPY

YoY+1.1 B of JPY

5,000

FY20224,000
FY20213,000

FY2020
2,000

1,000
Jan.

Feb.

Mar.

Apr.

May

Jun.

Jul.

© 2023 NAKANISHI INC.

Aug.

Sep.

Oct.

Nov.

Dec.
21

Global trend of net sales
B of JPY

Sales recovered in Japan and Asia, with higher sales in all regions in the second half

Europe 15.4
H1

7.7

H2

7.6

YoY

DentalSurgicalIndustrial+10.2 %YoY

DentalSurgicalIndustrial+12.8 %YoY

DentalSurgicalIndustrial+7.6 %

Japan

8.8

H1

4.4

H2

4.4

YoY

DentalSurgicalIndustrial-5.8 %YoY

DentalSurgicalIndustrial

YoY

DentalSurgicalIndustrial

YoY

DentalSurgicalIndustrial

YoY+28.2 %

DentalSurgicalIndustrial

H1

5.4 +42.5 %DentalSurgicalIndustrial

H2

5.1 +15.8 %-21.2 %YoY

N. America 10.6

+16.6 %

S. America, Middle East, Russia, Australia, etc.

Asia

7.0

-1.2 %

H1

3.4-6.0 %

H2

3.6

YoY

YoY

YoY

DentalDentalDentalSurgicalSurgicalSurgicalIndustrial

Industrial

Industrial+3.9 %© 2023 NAKANISHI INC.

Others

6.6

H1

3.3

+11.5 %

H2

3.2

+11.9 %YoY

DentalSurgicalIndustrial

DentalSurgicalIndustrial

DentalSurgicalIndustrial+11.7 %
YoY

YoY

22

Progress of Mid Term Management Plan “ NV2025+” - Sales and profit target/KPI
M of JPYMid Term Management Plan “NV2025+”

140
135
130
125
EUR (JPY)120
USD (JPY)115
110
105

137.90130.39131.00130.08グラフ タイトル

126.87122.53130.77122.01124.00112.39110.57109.37106.67109.8444,85734,34136,54335,418

9,467

9,721

9,299

55,00048,67133,055Net sales (M of JPY)

OP profit (M of JPY)

2020 - 2025

13,75016,50015,389

8,542

2017

2018

2019

2020

2021

2022

2023

2024

2025

ROE

(%)

12.4

11.7

10.2

8.7

12.7

14.4

>11.0

Total payout ratio

(%)

30.7

35.4

36.6

40.3

43.5

51.5

50.0

(month)

12.3

12.1

14.1

16.0

13.5

11.1

<12.0

Cash & marketable securities tomonthly sales ratio© 2023 NAKANISHI INC.

23

Mid Term Management Plan “NV2025+”: Progress in FY2022
Turn the COVID-19 pandemic into an opportunity to expand business scale.
Promoting initiatives to increase production capacity.
Mid Term Management Plan Rolling Plan

NV 2025 +Progress in FY2022

Basic Policy and Priority Measures

Performance results reached record
highs for two consecutive fiscal years
Significant increase in sales and sharein the U.S. market

1. Strategic expansion in Dental global market
2. Growing new business for customer needs insuper population ageing
3. Establish infrastructure for speedy productdevelopment and leading cost competitiveness

Built a factory for knockdown productionin China
Preparation for increased parts
production and automation at “A1+”.
Advanced the plan to build a newassembly factory “M1”

© 2023 NAKANISHI INC.

24

Mid Term Management Plan “NV2025+”: Focus market statusU.S.

Our market share has expanded for seven consecutive fiscal years whilethat of competitors have remained sluggish. Record highs were achieved.

Product lineup that captures the shift to electric motors
Promote collaboration with DCI International, LLC.,
the No.2 dental chair manufacturer in the U.S.

Expansion of transactions
with major dealers

Approach to dental universities

Approach to DSO*1
Ti-Max Z series

NLZ(Contra angles)(Micromotors)

Collaboration with DCI*1 Dental Service Organization© 2023 NAKANISHI INC.

25

Mid Term Management Plan “NV2025+”: Focus market status

China

Strengthen manufacturing and sales systems to ensure
appropriate response to local policies
Knockdown
production
factory

Beijing Sales Office Opened in 2021

四川中西齿科设备制造有限公司

NSK Dental Manufacturing Co., Ltd.

Despite the impact of the zero-COVID policy, suspensionof visa issuances, and other factors, the start up of theknockdown factory is proceeding smoothly. Shipments
to the Chinese market are expected to start this spring.

Jinan Sales Office Opened in 2022
Xi’an Sales Office Opened in 2022
NSK Shanghai
Expanded in 2020

Ziyang Knockdown Production Factory
Opened in 2022

Guangzhou Sales Office Opened in 2022
Shenzhen Sales Office Opened in 2022
© 2023 NAKANISHI INC.

26

Operation started at the new factory “A1+”A1+

Operating as a core production base to achieve mid- to long-term growth

Increased parts
production capacity

Installed 100 machine tools and 24-hour
operations began as a precision parts
factory. There is still room for expansion as a
production area, and facilities can beenhanced as the business scale expands.

Improved productivity

Streamlined the processing process that used
to take four processes with scattered machine
tools into a single machine. Created a
successful case of productivity improvement
and promoted the change to the existingproduction lines in the same manner.
© 2023 NAKANISHI INC.

Cultivation of techniciansStarted an off-the-job program for humanresource development to speed up andhomogenize the upskilling of employees
assigned to the Manufacturing Division.

27

Construction plan of new factory “M1”

M1

New assembly factory andparts and finished goods warehouse

Planned Location:

In the premises of Headquarters

Total floor area:

Approx. 20,000 m2

Investment: Approx.

8.5 billion yen

Construction Start:

April 2023 (scheduled)

Operation Start:

First phase: December 2024 (scheduled);
Second phase: December 2025 (scheduled)

Nakanishi Headquarters “SUNNY CAMPUS”

Increased
Production

New Factory

Headquarters R&D Center

“M1”

“RD1”

Improved
Efficiency

Shorter
Lead Time© 2023 NAKANISHI INC.

Promotion ofEnergyConservation

BetterWork
Environment

28

Sustainability topics

Environment

SocialGovernance

Carbon neutrality achieved at
headquarters factory and A1 factoryAwarded the JEED President’s
Effort Award for Excellence in
Employing Persons with Disabilities

Established Nomination andRemuneration Committee

Improved ESG evaluation(GHG Protocol Scopes 1 and 2)(Award for employing persons with disabilities)(Voluntary advisory body to the Board of Directors)(Review and update of registration information)

Structure of the Committee
Chairperson: Eiichi Nakanishi(Representative Directors)

Members:

Yuji Nonagase(Independent Outside Director)

May 2021 Calculation of greenhouse gas(GHG) emissions

Yukiko Araki

Sep. 2022 Purchased J-Credits fromTOCHIMOU Wood Industry*Scope 1 carbon neutrality
Oct. 2022 Acquired third-party certification ofcarbon neutrality

MSCI
2020

B

2021

BB

2022

BBB

(Independent Outside Director)

Aug. 2021 Issued Sustainability Report 2021
Presented “Green Plan 2030”
Dec. 2021 Switched to 100% renewableenergy for electricity at
headquarters and A1 Factory*Scope 2 carbon neutrality

RatingWhile promoting various measures related todiversity and inclusion, we received the JEED
President’s Effort Award in recognition of ourefforts to promote various support programs
to improve and establish a workplaceenvironment for the employment of persons
with disabilities.

Activity history

Sustainalytics

Jul. 1

Established the Committee

2020 High Risk

Aug. 9

1st committee meeting (online)

Oct. 7

2nd committee meeting (online)

2021 High Risk

Nov.11

3rd committee meeting (on-site)2022 Medium Risk

Dec. 23

4th committee meeting (online)© 2023 NAKANISHI INC.

29

Forecast of market trends and basic strategy

Forecast of market trends in 2023
- Demand -- Supply -Despite increasing uncertainty
about the future, demand is
expected to remain firm.

Expect parts prices continue tobe high while parts shortages
would ease gradually

Basic Strategy for 2023
Expand production capacity to meet growing global demand
Sales expansion in key markets, the U.S. and China
Steadily execute the construction plan of a new assembly factory “M1”

© 2023 NAKANISHI INC.

30

Dental business outline 1/3
Japan

Overview of
FY2022

Sales
trend

YoY

Decline in demand after thetermination of subsidies bottomedout and sales began to increase in H2.
Steady growth in OEM business
Oct. 22 – 23, 2022

Sales
trend

YoY

Capturing the demand recovery
phase, expand sales of handpieces
for dental treatment and implant
motors, our main products.
Further enhance preventive
dentistry products.

TOKYO DENTAL SHOW

EuropeOverview of
FY2022

Sales
trend

YoY

Sales at local subsidiaries in the
U.K., Sweden, and Spain were strong,
although regional differences wereobserved.
Strong sales at NSK Dental Nordic
Nov. 28 – Dec. 2, 2022

Measures for
FY2023

ADF2022 (France)© 2022 NAKANISHI INC.

Measures for
FY2023

Sales
trend

YoY

Expand sales of own brands basedon local subsidiaries to maximize
the capture of steady demand.
Increase presence and expand
product sales by participating in
IDS2023, the world’s largest exhibition.

31

Dental business outline 2/3
North
America

Overview of
FY2022

Sales
trend

YoY

Significant growth in sales throughmajor dealers covering the entire
U.S. Market share reached a recordhigh.
Successful collaboration with DCI
Nov. 26 – 29, 2022

Sales
trend

YoY

Continue sales expansion of ourmain products
Approach dental universities andDSO
Enhance collaboration with DCI

Greater New York (U.S.)

Asia

Overview of
FY2022

Sales
trend

YoY

Sales declined due to significant
impact of lockdowns and zeroCOVID policy
Sales to Southeast Asia recovered.
Oct. 7 – 9, 2022

Measures for
FY2023

Measures for
FY2023

Sales
trend

YoY

Aim for a significant increase in sales as a result of
normalization of sales activities as zero-COVID
policy was changed and of responding to limited
bidding for domesticallyproduced products bystarting knockdown production.

Decline in sales is expected in Southeast
Asia countries.

IDEM2022 (Singapore)© 2022 NAKANISHI INC.

32

Dental business outline 3/3
OthersOverview of
FY2022

Sales
trend

YoY

Measures for
FY2023

Sales
trend

YoY

MiddleEast

Sales grew due to ongoing recovery
in demand after the COVID-19 pandemic.

Expect an increase in sales bycontinuing to respond to bidding
for governmental hospitals anduniversity hospitals.

South
America

Amid the continuing boom, sales grew
substantially as we accelerated ourefforts to capture market share after
competitors withdrew from the market.

Expect a significant increase insales by expanding sales of our main
products including implant motors.

Feb. 1 – 3, 2023

AEEDC2022 (UAE)

Sales in Russia declined sharply,
while sales in CIS countries increased.

RussiaContinued sales in Ukraine via Germany.

Sales in Australia continued to growby steadily capturing strong demand.

Australia
Jan. 25 – 28, 2023

CIOSP2023 (Brazil)© 2022 NAKANISHI INC.

Aim for sales recovery by steadily
capturing strong demand in CIS
countries.

Sales are expected to remain flat as theprevious fiscal year by promoting main
products, although there is an increased
uncertainty over future demand33Surgical business outline
Overview of FY2022
Achieved record-high sales due to successful global sales promotion campaigns and sales expansion of burs
YoY

Japan

Sales grew due to stable supply through domestic production, steadily capturing demand from new customers.

YoY

EuropeAchieved sales plan with sales growth in Germany, Italy, and Spain. Sales were on a par with FY2021.

YoY

N. America

Sales expanded against a backdrop of high reputation of our products. Together with channels through an alliance withpartners, sales increased significantly.

YoY

Asia

Sales turned out to be about the same as FY2021 since, in China, sales grew after the lifting of the lockdown, while sales
growth was sluggish in other Asian countries.

Measures for FY2023
Expect increased sales in N. America and Asia, while decreased sales in Europe due to loss of OEM business.
YoY

Japan

Continue to strengthen cooperation with KOLs in the otology field. Domestic sales, which grew in FY2022, are expected toslow down.

YoY

EuropeLarge-scale renewal projects will lull. Expect decreased sales due to loss of OEM business

YoY

N. America

Against a backdrop of high reputation of our products, an alliance with partners is proceeding smoothly, and sales are
expected to increase.

YoY

Asia

In China and other Asian countries where demand has entered a recovery phase, we will continue to expand the dealer
network and promote sales expansion.
© 2023 NAKANISHI INC.

34

Surgical business topics

Continued approach to the otology field

October 20, 2022 at PACIFICO Yokohama North

Hands-on seminar on temporal bones
at the 32nd Annual Meeting of The
Japan Otological Society© 2023 NAKANISHI INC.

35

Industrial business outline
Overview of FY2022
Despite a slowdown in production due to parts shortages, fulfilled orders received and achieved record-highsales for two consecutive fiscal years.
YoY

Japan

Production continued to be unable to keep up with the large number of orders from a wide range of industries.

YoY

EuropeAppealing application case studies have been successful, and the switch from other companies to NSK has been proceeding.

YoY

N. America

Strengthening of the sales structure has been successful. Sales grew due to fulfillment of orders received which were steadily
accumulated.

YoY

Asia

Despite brisk orders, longer lead time due to parts shortages became normal. Sales declined as shipments could not keep up
with the orders.

Measures of FY2023
Incorporating of Alfred Jäger GmbH into the Company Group dramatically increased our presence in the industry.
Aim to create synergy through cross-selling.
YoY

Japan

Sales are expected to decline with the inability to meet demand due to longer lead time caused by a shortage of electronicparts.

YoY

EuropeInquiries to Alfred Jäger are strong, and a significant increase in sales is expected in line with the new consolidation.

YoY

N. America

Strengthen the sales structure and expand the dealer network. Sales are expected to decline due to the impact of longer lead
time.

YoY

Asia

Although delivery dates continue to be prolonged, sales remain flat as the previous fiscal year due to the execution of a large
number of back orders.
© 2023 NAKANISHI INC.

36

Alfred Jäger - company profile

Specialized manufacturer of industrial spindles

Founded:1967

Established:

November 2000

Headquarters:

Ober-Moerlen GERMANY

Main product:

High-frequency spindles
High performance motors

Employee:

120

Headquarters and motor factory

Spindle factory

Product lineup

Main application DentalCAD/CAM

Business segment: Industrial Business37

NAKANISHI ✖ Jäger
Each has a different application, product characteristics and main market

Automobile, Smart Phone, Robot,
PCB, Medical Equipment, etc.

Application
by industry

Dental CAD/CAM,
PCB, Robot, etc.

Φ 19 - Φ 50 mm

Diameter ofmain productΦ 30 - Φ 150 mm

1,200 watts

Maximum
power

20,000 watts

150,000 rpm (Pneumatic)
80,000 rpm (DC)Maximum
speed

120,000 rpm (DC/AC)

Pneumatic motor
DC brushless motor

Motor
technology

DC/AC high-frequency motor

Modular type spindle

Spindle – Motor
construction

Integrated spindle

Japan, Asia, USA

Main
marketEurope© 2023 NAKANISHI INC.

38

Industrial business topics

JIMTOF2022

Participated in one of the largest machine tool trade fairs in Japan for the first time in 4 years.
Many examples of collaboration with system integrators (25 companies) were exhibited.

November 8 to13, 2022 at Tokyo Big Sight© 2023 NAKANISHI INC.

39